Structure

In general, P450s are 450-500-amino-acid (55-60 kDa) proteins with a completely conserved C-terminal cysteine residue that provides the thiolate coordinate bond to the iron atom which tethers the heme prosthetic group. Intracellularly, P450s reside in the soluble fraction of the cell (bacterial enzymes), the inner membrane of the mitochondrion (several steroid-metabolizing P450s), or the endoplasmic reticulum (drug-metabolizing P450s); targeting is dependent on the nature of the N-terminal leader sequence.10 Drug-metabolizing P450s contain a hydrophobic string of 20-30 amino acids that is inserted into the endoplasmic reticulum and anchors the enzyme to the membrane, with the bulk of the protein oriented towards the cytosol in a monotopic fashion.

Until 2000, P450 tertiary structure information was limited to the soluble bacterial forms of the enzyme (e.g., CYP101/P450cam and CYP102/P450 BM3). The availability of the first mammalian P450s structure, an N-terminally truncated form of rabbit CYP2C5 also engineered internally to limit additional membrane or oligomer interactions, confirmed that the global features of this enzyme evident for the early bacterial structures were conserved, viz., a heart-shaped protein with an alpha-helix-rich C-terminus and a beta-sheet-rich N-terminus.11 At the time of writing, crystal structures for human CYP2C9, CYP2C8, CYP3A4, and CYP2A6 have been solved.12-15 Notably, the structure for

Cyp2a6 Orientation Endoplasmic Reticulum

Figure 1 Crystal structures of CYP3A4 and CYP2C9. (a) The overall structural fold of CYP3A4 and location of the heme prosthetic group (ball and stick). Secondary structure elements are represented as coils for helices and arrows for strands. (b) and (c) contrast the solvent accessible molecular surfaces of the active sites of CYP3A4 (green) and CYP2C9 (magenta). These structures highlight differences in volume and shape of P450 active sites. (Reproduced with permission from Williams, P. A.; Cosme, J.; Vinkovic, D. M.; Ward, A.; Angove, H. C.; Day, P. J.; Vonrhein, C.; Tickle, I. J.; Jhoti, H. Science 2004, 305, 683-686. Copyright (2004) AAAS.)

Figure 1 Crystal structures of CYP3A4 and CYP2C9. (a) The overall structural fold of CYP3A4 and location of the heme prosthetic group (ball and stick). Secondary structure elements are represented as coils for helices and arrows for strands. (b) and (c) contrast the solvent accessible molecular surfaces of the active sites of CYP3A4 (green) and CYP2C9 (magenta). These structures highlight differences in volume and shape of P450 active sites. (Reproduced with permission from Williams, P. A.; Cosme, J.; Vinkovic, D. M.; Ward, A.; Angove, H. C.; Day, P. J.; Vonrhein, C.; Tickle, I. J.; Jhoti, H. Science 2004, 305, 683-686. Copyright (2004) AAAS.)

CYP2C9 with the flurbiprofen bound shows an important salt bridge interaction between an active site Arg108 residue and the charged carboxylate of this nonsteroidal anti-inflammatory drug, which helps explain this isoform's relative selectivity for acidic substrates.16 A comparison of the active site of CYP3A4 and CYP2C9 is depicted in Figure 1. In some cases, ligands have been crystallized within the P450 active site in multiple conformations, highlighting the plasticity of mammalian P450 active sites. This is in accord with the long-held observations of the broad substrate specificity of these enzymes.11

Was this article helpful?

0 0
Lower Your Cholesterol In Just 33 Days

Lower Your Cholesterol In Just 33 Days

Discover secrets, myths, truths, lies and strategies for dealing effectively with cholesterol, now and forever! Uncover techniques, remedies and alternative for lowering your cholesterol quickly and significantly in just ONE MONTH! Find insights into the screenings, meanings and numbers involved in lowering cholesterol and the implications, consideration it has for your lifestyle and future!

Get My Free Ebook


Post a comment